Clinical Trials in Oncology East Coast 2026

Choose Avance Clinical for Oncology Clinical Trials

Your next trial deserves a partner with proven oncology experience, extensive international reach, and the agility which biotech sponsors depend on. As a specialist oncology Contract Research Organization (CRO) with a dedicated Oncology Center of Excellence, we leverage a global footprint, early‑phase operational excellence, and a strong focus on cancer research.

Here are a few key advantages that set Avance Clinical apart in oncology clinical development:

• Over 260 oncology trials conducted in the past five years, including multiple repeat collaborations – delivering focused early‑phase execution across a wide range of malignancies while improving learning curves, feasibility, and protocol design.
• Comprehensive support from Phase I/early phase through Phase II+ and Late phase, across Australia, Asia, and the United States.
• Deep experience across both hematological malignancies and solid tumors, including NSCLC, melanoma, ovarian, glioblastoma, and rare oncology indications.
• Strategic global footprint for a seamless multi‑region development pathway, including Australia’s efficient start‑up environment and R&D rebate ecosystem, expanded North American operations, and strong presence across Asia.

What to Expect at Our Booth

At Booth 6, you’ll meet our oncology‑focused team, ready to discuss:

• How Avance Clinical can support your next oncology program, whether you’re planning a first‑in‑human, dose‑escalation/expansion, combination study, or a large Phase II trial.
• Insights into our ClinicReady and GlobalReady model: start agile and cost‑efficient in Australia/Asia, then expand seamlessly into the U.S. or other global regions.
• How our global site network, oncology focus, and regulatory expertise accelerate timelines, strengthen data integrity, and enable global read‑out readiness.

Schedule a Meeting

Book a meeting through our website and select “OCT Oncology East” when booking. Let’s set aside time to discuss advancing your oncology therapeutic to the next stage.